-+ 0.00%
-+ 0.00%
-+ 0.00%

Mirum Pharma CMO Rob Myers files initial beneficial ownership statement

PUBT·09/23/2026 01:53:04
Mirum Pharma CMO Rob Myers files initial beneficial ownership statement
  • Mirum Pharmaceuticals Chief Medical Officer Robert Paul Myers filed an initial Form 3 disclosing direct ownership of 55 shares of common stock.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002155916-26-000003), on September 22, 2026, and is solely responsible for the information contained therein.